The authors reply
- PMID: 33730743
- DOI: 10.1097/CCM.0000000000004992
The authors reply
Conflict of interest statement
Dr. Lozano received funding from Grifols. The remaining authors have disclosed that they do not have any potential conflicts of interest.
Comment on
-
Plasma Exchange: An Effective Rescue Therapy in Critically Ill Patients With Coronavirus Disease 2019 Infection.Crit Care Med. 2020 Dec;48(12):e1350-e1355. doi: 10.1097/CCM.0000000000004613. Crit Care Med. 2020. PMID: 32833695 Free PMC article.
-
Plasmapheresis Efficiency in Coronavirus Disease 2019: More Related to What You Add and Not What You Take Away?Crit Care Med. 2021 Jun 1;49(6):e651-e652. doi: 10.1097/CCM.0000000000004926. Crit Care Med. 2021. PMID: 33769769 No abstract available.
References
-
- Jamme M, Mazeraud A. Plasmapheresis Efficiency in Coronavirus Disease 2019: More Related to What You Add and Not What You Take Away? Crit Care Med. 2021; 49:e651–e652
-
- Fernandez J, Gratacos-Ginès J, Olivas P, et al.; Covid Clinic Critical Care (CCCC) Group. Plasma exchange: An effective rescue therapy in critically ill patients with coronavirus disease 2019 infection. Crit Care Med. 2020; 48:e1350–e1355
-
- Bastard P, Rosen LB, Zhang Q, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020; 370:eabd4585
-
- Arroyo V, García-Martinez R, Salvatella X. Human serum albumin, systemic inflammation, and cirrhosis. J Hepatol. 2014; 61:396–407
-
- Fernández J, Clària J, Amorós A, et al. Effects of albumin treatment on systemic and portal hemodynamics and systemic inflammation in patients with decompensated cirrhosis. Gastroenterology. 2019; 157:149–162
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources